Skip to main content
Intermediate Technical IVT

MCADD

Pronunciation: EM-cad

Also written as: MCADD — medium-chain acyl-CoA dehydrogenase deficiency

Medium-chain acyl-CoA dehydrogenase deficiency, a fatty acid oxidation disorder causing episodic metabolic crises.

Full Definition

Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is the most common fatty acid oxidation disorder, affecting the body's ability to break down medium-chain fatty acids for energy. Infants with MCADD can develop severe hypoglycemia, vomiting, and lethargy during periods of fasting or illness, potentially leading to coma or death. Early identification through newborn screening allows families to prevent metabolic crises through frequent feeding and avoidance of fasting.

Usage

Usage note: Distinguish from other acyl-CoA dehydrogenase deficiencies in reports.

In Context

  • "MCADD screening showed elevated C8 acylcarnitine requiring genetic confirmation." — Follow-up protocol
  • "The emergency department protocol for known MCADD includes immediate glucose monitoring." — Clinical guideline

Also known as

medium-chain acyl-CoA dehydrogenase deficiency ACADM deficiency

Don't confuse with

VLCADD LCHADD other fatty acid oxidation disorders

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON